Consulting and advisory services for gmp, risk analysis, new product development strategy
Product Description
Explicat Pharma GmbH
-
Country/Region:Germany
-
On CPHI since:2015
-
Employees:1 - 24
Company types
Categories
Specifications
Explicat Pharma GmbH
-
Country/Region:Germany
-
On CPHI since:2015
-
Employees:1 - 24
Company types
More Products from Explicat Pharma GmbH (2)
-
Product Technical Due Diligence
For companies that are:
• Buying a Product outright • In-licensing a Product • Acquiring or Licensing Technology • Acquiring a Division • Acquiring a whole Company
To cover the wide range of disciplines involved in Technical Due Diligence, Explicat® Pharma provides clien... -
Product Technical Project Management
“You have an early development candidate – we take the responsibility to develop it and get it on the market”
We use an integrated fast-track drug development approach to achieve this goal.
• Sourcing • Chemical Development / Biotechnological Development • Pharmaceutical Develo...
Explicat Pharma GmbH resources (1)
-
Whitepaper A CASE STUDY TO OPTIMIZE FREEZE DRYINGCONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS
SBECD (Sulfobutylether - β - Cyclodextrin) is a new andpromising excipient for freeze dried formulations. Thepresent study illustrates an approach to optimize freezedrying conditions for formulations containing SBECD.First, a placebo was used to evaluate a general freezedrying recipe. Further, the information gained wascompared with drug product runs.
(PDF) A CASE STUDY TO OPTIMIZE FREEZE DRYING CONDITIONS OF CYCLODEXTRIN-BASED FORMULATIONS. Available from: https://www.researchgate.net/publication/331642211_A_CASE_STUDY_TO_OPTIMIZE_FREEZE_DRYING_CONDITIONS_OF_CYCLODEXTRIN-BASED_FORMULATIONS [accessed Jul 26 2023].